NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia

Walden University NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders-Step-By-Step Guide

This guide will demonstrate how to complete the Walden University NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.

How to Research and Prepare for NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders

Whether one passes or fails an academic assignment such as the Walden University NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.

After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.

How to Write the Introduction for NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders

The introduction for the Walden University NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.

Need a high-quality paper urgently?

We can deliver within hours.

PLACE AN ORDER

How to Write the Body for NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders

After the introduction, move into the main part of the NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.

Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.

How to Write the Conclusion for NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders

After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.

How to Format the References List for NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders

The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.

Stuck? Let Us Help You

Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease.

Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW.

Sample Answer for NRNP 6675 Week 5 Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders

Subjective:

CC (chief complaint): Mr. Sherman Tremaine reports that he has been seeing people watching him and can hear them.

HPI: Mr. Tremaine reports that he has come for a psychiatric evaluation following his sister’s persuasion. He reports that in the past weeks, he has noticed people outside his window watching him. He also says he can hear them and see their shadows. He says that this has bothered him, making him sleep less due to the loud voices, and he does not watch the television often as the people watch him through the screen. He also believes that the government has sent them and thinks the sister is conspiring with them by tapping his phone, making his taxes high. He has been locking his fridge as he thinks they will poison his food and does not go to the grocery store as the people are following him. He takes alcohol and smokes but denies using marijuana and cocaine. He has never experienced any seizures, blackouts, hallucinations, or delusions after taking the alcohol or drugs. His prior prescriptions include Haldol, Seroquel, risperidone, and Thorazine. He reports he no longer takes them as he hates Haldol and Thorazine, thinks Seroquel is poisonous, and cannot use risperidone as it had caused breast enlargement. His father had paranoid schizophrenia, and his mother had anxiety. In addition, he denies suicidal ideations and has never been married or arrested. He lives alone, has attained education up to grade 10, and is unemployed.

Substance Current Use: The patient reports he smokes around three packs daily and drinks a 12-pack of alcohol for a week.

Medical History: He has diabetes and has a prior diagnosis of fatty liver disease.

Current Medications: He is on metformin for his diabetes and quetiapine.
Allergies: He has no allergies.

Reproductive Hx: He has no children.

ROS:

GENERAL: The patient was not in any discomfort and denied nausea.
HEENT: There was no ear pain, eye redness, and nasal discharge.
SKIN: There were some scars on his feet but the hair distribution was normal. There were no pustular or erythematous lesions.
CARDIOVASCULAR: Palpitations, orthopnea, and paroxysmal nocturnal dyspnea were all absent
RESPIRATORY: Dyspnea, cough, and chest pain were absent.
GASTROINTESTINAL: There was no abdominal pain or distension, jaundice, or changes in bowel movements.
GENITOURINARY: There was polyuria but no dysuria, hematuria, and urinary retention.
NEUROLOGICAL: There were no headaches, abnormal sensations, and vertigo.
MUSCULOSKELETAL: There was no joint pain and stiffness or muscle pain and weakness.
HEMATOLOGIC: There was no abnormal bruising, high fevers, and easy fatiguability.
LYMPHATICS: There was no lymph node swelling or pain.
ENDOCRINOLOGIC: There was no abnormal weight gain or loss and breast development.

Objective:

Diagnostic results: No diagnostic tests were ordered.

Assessment:

Mental Status Examination: The patient was alert and well-groomed. He was also oriented in time, person, and place and spoke at a normal rate but in a low tone. He was agitated, had a dysphoric mood, and blunt affect. He also has incoherent thoughts, paranoid and persecutory delusions, and auditory and visual hallucinations. He also has a normal span and is easily distracted. He also has an intact memory with confabulations. He has impaired judgment, partial insight, and abstract thought.

Diagnostic Impression:

Schizophrenia: Schizophrenia is the most probable diagnosis for this patient. It is an example of a DSM-V psychotic disorder characterized by hallucinations, delusions, disorganized thoughts and speech, and abnormal behavior, which have lasted for more than six months (Lundin et al., 2024). Mr. Tremaine has met the disease symptomatology and duration for this condition. Some schizophrenic patients may also experience negative symptoms such as avolition, blunt affect, mutism, and negativism, which are absent in Mr.Tremaine.

Schizophreniform: Schizophreniform is an example of a DSM-V psychotic disorder that has similar symptoms to schizophrenia. However, Mr Tremaine does not meet the schizophreniform diagnostic criteria (Lundin et al., 2024). This is because schizophrenic symptoms should have lasted for a month to six months, but in this case, they seem to have lasted much longer.

Substance-induced psychotic disorder (SIPD): SIPD is also another example of DSM-V psychotic disorder with hallucinations and delusions as its main symptoms. DSM-V states that the symptoms should be caused by a substance capable of inducing psychosis, such as alcohol, cannabis, or cocaine (Lundin et al., 2024). Mr.Tremaine meets that criteria as he often takes alcohol but does not meet the diagnostic criteria where the symptoms occur during or soon after intoxication, as his symptoms are present even before intoxication.

Case Formulation and Treatment Plan:

Psychotherapy: I would recommend cognitive-behavioral therapy (CBT) as the first-line psychotherapy method for this patient. The use of CBT among schizophrenic patients has had significant improvements in positive and negative symptoms and social functions (Xu et al., 2023). It also improves the disease prognosis, problem-solving skills, and quality of life. It also reduces the risk of relapse.

Pharmacotherapy: I can prescribe an atypical antipsychotic, olanzapine 10 mg PO (Kolli et al., 2023).

Alternative therapy: I would also recommend psychoeducation as an alternative form of psychotherapy for Mr. Tremaine. Psychoeducation aims to inform patients about their illness, its symptoms, treatment, and prognosis (Herrera et al., 2023). It also helps educate them on problem-solving training and communication while promoting self-assertiveness to boost their self-esteem and confidence.

Health promotion and patient education: I would encourage Mr. Tremaine to avoid alcohol consumption as it may complicate or cause a relapse of his prior fatty liver disease (Varghese et al., 2022). I would also encourage him to quit smoking and inform him of the impact of smoking on his health, including increasing his risk of non-healing diabetic ulcers.

I would also educate him on the importance of treatment adherence, including medication and psychotherapy, and inform him about the advantages of both to his diagnosis (Saijonkar et al., 2023).

Reflections: My next sessions will explore the patient’s symptoms. First, I would inquire about his past psychiatric history and the symptoms Mr.Tremaine has experienced in the past, including the onset. In addition, I would wish to explore his medication history and help him understand that every medication previously prescribed was meant to alleviate his symptoms despite the side effects (Díaz-Castro et al., 2021). I would also like to involve his sister and educate her about Mr. Tremaine’s condition, the family’s psychiatric history, and how she can offer him support. I would also tell her to avoid giving the brother alcohol and cigarettes to help promote his physical and mental well-being.

References

Díaz-Castro, L., Hoffman, K., Cabello-Rangel, H., Arredondo, A., & Herrera-Estrella, M. Á. (2021). Family History of Psychiatric Disorders and Clinical Factors Associated With a Schizophrenia Diagnosis. Inquiry: A Journal of Medical Care Organization, Provision and Financing, 58. https://doi.org/10.1177/00469580211060797

Herrera, S. N., Sarac, C., Phili, A., Gorman, J., Martin, L., Lyallpuri, R., Dobbs, M. F., DeLuca, J. S., Mueser, K. T., Wyka, K. E., Yang, L. H., Landa, Y., & Corcoran, C. M. (2023). Psychoeducation for Individuals at Clinical High Risk for Psychosis: A Scoping Review. Schizophrenia Research, 252, 148. https://doi.org/10.1016/j.schres.2023.01.008

Kolli, P., Kelley, G., Rosales, M., Faden, J., & Serdenes, R. (2023). Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions. Pharmacogenomics and Personalized Medicine, 16, 1097-1108. https://doi.org/10.2147/PGPM.S391401

Lundin, N. B., Blouin, A. M., Cowan, H. R., Moe, A. M., Wastler, H. M., & K Breitborde, N. J. (2024). Identification of Psychosis Risk and Diagnosis of First-Episode Psychosis: Advice for Clinicians. Psychology Research and Behavior Management, 17, 1365-1383. https://doi.org/10.2147/PRBM.S423865

Saijonkari, M., Paronen, E., Lakka, T., Tolmunen, T., Linnosmaa, I., Lammintakanen, J., Isotalo, J., Rekola, H., & Mäki-Opas, T. (2023). Promotive and preventive interventions for mental health and well-being in adult populations: A systematic umbrella review. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1201552

Varghese, J., & Dakhode, S. (2022). Effects of Alcohol Consumption on Various Systems of the Human Body: A Systematic Review. Cureus, 14(10). https://doi.org/10.7759/cureus.30057

Xu, F., & Zhang, H. (2023). The application of cognitive behavioral therapy in patients with schizophrenia: A review. Medicine, 102(32). https://doi.org/10.1097/MD.0000000000034827